BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 1, Issue 1
  • This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (5831)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-1) series, Tables (1-1) series.
Item 
Count 
PDF458
HTML2935
Figures (1-1)1206
Tables (1-1)1232
 Sum=5831
Oct 15, 2009 (publication date) through Nov 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastrointestinal Oncology
ISSN
1948-5204
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Guidelines For Clinical Practice
Copyright ©2009 Baishideng.
World J Gastrointest Oncol. Oct 15, 2009; 1(1): 38-40
Published online Oct 15, 2009. doi: 10.4251/wjgo.v1.i1.38
Table 1 Impact of VTE on survival in the NCI-CTG PA.3 study
VariableHR95% CIP value
Treatment effect
Erlotinib0.790.66-0.950.01
Placebo1.0
Thrombosis effect
VTE2.331.82-2.98< 0.0001
No VTE1.0
Performance status
ECOG 2+1.691.35-2.12< 0.0001
ECOG 0-11.0
Extent of disease
Local0.600.48-0.74< 0.0001
Distant1.0
Reprinted with permission© 2008 American Society of Clinical Oncology. All rights reserved. VTE: Vascular thromboembolic disease.
Full Size Table
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345